title: Clinical pharmacokinetics of a new antiandrogen Anandron (RU 23908).
authors: Roswell Park Memorial Institute, Buffalo, New York.
authors: L
authors: L
authors: Pendyala
authors: P J
authors: PJ
authors: Creaven
authors: R
authors: R
authors: Huben
authors: D
authors: D
authors: Tremblay
authors: M
authors: M
authors: Mouren
authors: C
authors: C
authors: Bertagna
mesh_terms: D000726:Androgen Antagonists / Q000493:pharmacokinetics*; D002250:Carbon Radioisotopes; D006207:Half-Life; D006801:Humans; D007093:Imidazoles / Q000493:pharmacokinetics*; D048289:Imidazolidines; D008297:Male; D008991:Monitoring, Physiologic
chemical_list: D000726:Androgen Antagonists; D002250:Carbon Radioisotopes; D007093:Imidazoles; D048289:Imidazolidines; C021277:nilutamide